Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 33.80
+0.70 (2.11%)
At close: Oct 24, 2025
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 14.45 billion as of October 24, 2025. Its market cap has increased by 3.86% in one year.
Market Cap
14.45B
Enterprise Value
17.40B
Revenue
5.71B
Ranking
n/a
PE Ratio
29.51
Stock Price
33.80
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 14.45B, an increase of 521.30%. That is a compound annual growth rate of 11.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 14.45B | -4.90% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | 20.44B | -7.38% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.52T |
| Coloplast | 137.17B |
| Genmab | 117.60B |
| Demant | 49.93B |
| ALK-Abelló | 47.95B |
| H. Lundbeck | 43.82B |
| Zealand Pharma | 32.74B |
| Ambu A/S | 28.69B |